DavidSHanMD

Clinical Trials

• Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189 Start of enrollment: 2011 Feb 01

  Completed

  Phase 1

• A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects Start of enrollment: 2012 Jun 01

  Completed

  Phase 1

• A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients Start of enrollment: 2013 Mar 01

  Completed

  Phase 1

• AZD6423 SAD/MAD Study in Healthy Volunteers Start of enrollment: 2013 Sep 01

  Completed

  Phase 1

• A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers Start of enrollment: 2013 Aug 01

  Completed

  Phase 1

• SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease. Start of enrollment: 2014 Feb 04

  Completed

  Phase 1

• Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects Start of enrollment: 2014 Dec 01

  Completed

  Phase 1

• A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease Start of enrollment: 2017 May 15

  Completed

  Phase 1

• A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects Start of enrollment: 2019 Jan 16

  Completed

  Phase 1

• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects Start of enrollment: 2019 Jul 24

  Terminated

  Phase 1

• A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects Start of enrollment: 2023 Sep 06

  Completed

  Phase 1

• A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects Start of enrollment: 2019 Oct 28

  Completed

  Phase 1

• To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia Start of enrollment: 2019 Nov 21

  Completed

  Phase 1

• A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease Start of enrollment: 2020 Jul 22

  Completed

  Phase 1

• A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects Start of enrollment: 2022 Aug 30

  Recruiting

  Phase 1

• Join now to see all